Market Size of Global Kidney Function Tests Industry
Study Period | 2019 - 2029 |
Base Year For Estimation | 2023 |
CAGR | 5.62 % |
Fastest Growing Market | Asia Pacific |
Largest Market | North America |
Market Concentration | Medium |
Major Players*Disclaimer: Major Players sorted in no particular order |
Kidney Function Tests Market Analysis
The Kidney Function Tests Market is expected to register a CAGR of 5.62% during the forecast period, 2022-2027.
The pandemic has significantly impacted the kidney function tests market, as COVID-19 affected the patients' kidney function with the disease progression. According to a study titled "Association of Proteinuria and Hematuria with Acute Kidney Injury and Mortality in Hospitalized Patients with COVID-19" published in November 2020, more than 40% of admitted patients with COVID-19 showed symptoms of abnormal kidney function, such as albuminuria or hematuria. Furthermore, according to a study titled "Clinical Characteristics of COVID-19 Infection in Newborns and Pediatrics: A Systematic Review" published in April 2020, in adult patients, COVID-19 urinary incontinence was commonly found in patients with moderate to severe conditions. In children, exposure to COVID-19 has been reported among those who suffer from a mild form of COVID-19. From the onset of the disease, urinary tract infections were identified from day 1 to day 52. Thus, such instances notably impacted the growth rate of the market over the pandemic phase.
Furthermore, some of the factors driving the growth of the market include an increase in chronic kidney disease; the growing prevalence of underlying conditions such as diabetes and hypertension leading to kidney disorders; an increase in awareness about diagnostic methods for kidney function; and technological advances in diagnostic equipment and tools.
Diabetes and high blood pressure are considered major factors responsible for the growing burden of chronic kidney disease worldwide. Growing cases of diabetes will ultimately impact the growth of the market over the forecast period. For instance, according to the International Diabetes Atlas tenth edition in 2021, 537 million adults (20-79 years) were living with diabetes, approximately 1 in 10 individuals. This number is predicted to rise to 643 million by 2030 and 783 million by 2045.
Additionally, market players embrace a variety of strategies such as product launches, product developments, collaborations, acquisitions, integrations, and expansion to maximize their geographical reach worldwide. For example, in August 2020, RenalytixAI received approval from the United States Food and Drug Administration (FDA) for its new KidneyIntelX test. AI-enabled clinical trials are designed to identify and improve the clinical management of patients with type 2 diabetes and rapidly progressive kidney disease. The emergence of technologically advanced products is expected to further boost the market's growth over the forecast period.
Thus, the aforesaid factors are likely to have a positive impact on the market's growth. However, the high cost of diagnostic procedures and strict regulations are expected to hamper the kidney function tests market's growth in the near future.
Kidney Function Tests Industry Segmentation
As per the scope of the report, kidney function tests are simple procedures that generally use either blood or urine to help identify issues in the kidneys. The kidney function tests market is segmented by Product Type (Dipsticks, Disposables, and Reagents), Test Type (Urine Test (Urine Protein Tests, Creatinine Clearance Tests, and Microalbumin Tests), and Blood Tests (Serum Creatinine Tests, Glomerular Filtration Rate Tests, and Blood Urea Nitrogen Tests), End User (Hospitals and Clinics, Diagnostic Laboratories, and Other End Users), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.
By Product Type | |
Dipsticks | |
Disposables | |
Reagents |
By Test Type | |||||
| |||||
|
By End User | |
Hospitals and Clinics | |
Diagnostic Laboratories | |
Other End Users |
Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Global Kidney Function Tests Market Size Summary
The Kidney Function Test Market is poised for significant growth, driven by an increasing prevalence of chronic kidney diseases and underlying conditions such as diabetes and hypertension. The market has been notably influenced by the COVID-19 pandemic, which highlighted the impact of the virus on kidney function, thereby accelerating the demand for diagnostic tests. Technological advancements in diagnostic equipment and a growing awareness of kidney health are further propelling market expansion. The introduction of innovative products, such as AI-enabled tests and smartphone-powered home tests, is expected to enhance diagnostic capabilities and accessibility, contributing to market growth.
In North America, the market is bolstered by a robust healthcare infrastructure and a high incidence of urinary tract infections, alongside the need for post-transplantation kidney function assessments. The region's response to the COVID-19 pandemic, including the development of new diagnostic assays, has also played a crucial role in market dynamics. Despite challenges such as high diagnostic costs and regulatory hurdles, the market remains competitive, with major players like F.Hoffmann-La Roche Ltd., ACON Laboratories Inc., and Quest Diagnostics leading the charge. These companies are actively engaging in strategic initiatives, including product launches and collaborations, to expand their market presence and drive innovation in kidney function testing.
Global Kidney Function Tests Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Rising Prevalence of Chronic Kidney Diseases
-
1.2.2 Increasing Awareness about the Diagnostic Methods for the Proper Functioning of the Kidney
-
1.2.3 Technological Advancements in Diagnostic Machinery and Tools
-
-
1.3 Market Restraints
-
1.3.1 High Cost of Diagnostic Procedures
-
1.3.2 Stringent Regulations Norms
-
-
1.4 Porter's Five Forces Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION (Market Size by Value - USD Million)
-
2.1 By Product Type
-
2.1.1 Dipsticks
-
2.1.2 Disposables
-
2.1.3 Reagents
-
-
2.2 By Test Type
-
2.2.1 Urine Tests
-
2.2.1.1 Urine Protein Tests
-
2.2.1.2 Creatinine Clearance Tests
-
2.2.1.3 Microalbumin Tests
-
-
2.2.2 Blood Tests
-
2.2.2.1 Serum Creatinine Tests
-
2.2.2.2 Glomerular Filtration Rate Tests
-
2.2.2.3 Blood Urea Nitrogen Tests
-
-
-
2.3 By End User
-
2.3.1 Hospitals and Clinics
-
2.3.2 Diagnostic Laboratories
-
2.3.3 Other End Users
-
-
2.4 Geography
-
2.4.1 North America
-
2.4.1.1 United States
-
2.4.1.2 Canada
-
2.4.1.3 Mexico
-
-
2.4.2 Europe
-
2.4.2.1 Germany
-
2.4.2.2 United Kingdom
-
2.4.2.3 France
-
2.4.2.4 Italy
-
2.4.2.5 Spain
-
2.4.2.6 Rest of Europe
-
-
2.4.3 Asia-Pacific
-
2.4.3.1 China
-
2.4.3.2 Japan
-
2.4.3.3 India
-
2.4.3.4 Australia
-
2.4.3.5 South Korea
-
2.4.3.6 Rest of Asia-Pacific
-
-
2.4.4 Middle East and Africa
-
2.4.4.1 GCC
-
2.4.4.2 South Africa
-
2.4.4.3 Rest of Middle East and Africa
-
-
2.4.5 South America
-
2.4.5.1 Brazil
-
2.4.5.2 Argentina
-
2.4.5.3 Rest of South America
-
-
-
Global Kidney Function Tests Market Size FAQs
What is the current Global Kidney Function Tests Market size?
The Global Kidney Function Tests Market is projected to register a CAGR of 5.62% during the forecast period (2024-2029)
Who are the key players in Global Kidney Function Tests Market?
F.Hoffmann-La Roche Ltd, Nova Biomedical, Quest Diagnostics , 77 Elektronika Kft and ACON Laboratories, Inc. are the major companies operating in the Global Kidney Function Tests Market.